Appleton Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Sell
31,102
-884
-3% -$71.3K 0.15% 103
2026
Q1
$2.77M Sell
31,986
-214
-0.7% -$20.5K 0.19% 99
2025
Q4
$3.09M Sell
32,200
-693
-2% -$67.3K 0.2% 97
2025
Q3
$3.13M Buy
32,893
+91
+0.3% +$8.37K 0.21% 96
2025
Q2
$2.86M Sell
32,802
-2,092
-6% -$177K 0.2% 100
2025
Q1
$3.14M Buy
34,894
+1,590
+5% +$142K 0.24% 89
2024
Q4
$2.66M Sell
33,304
-898
-3% -$77.7K 0.2% 98
2024
Q3
$3.08M Sell
34,202
-1,665
-5% -$140K 0.23% 92
2024
Q2
$2.82M Sell
35,867
-1,443
-4% -$118K 0.22% 91
2024
Q1
$3.25M Sell
37,310
-9,228
-20% -$788K 0.25% 91
2023
Q4
$3.83M Sell
46,538
-1,596
-3% -$122K 0.31% 82
2023
Q3
$3.77M Sell
48,134
-970
-2% -$81.2K 0.34% 78
2023
Q2
$4.33M Sell
49,104
-6,366
-11% -$548K 0.37% 75
2023
Q1
$4.47M Sell
55,470
-5,581
-9% -$455K 0.4% 67
2022
Q4
$4.75M Sell
61,051
-15,552
-20% -$1.26M 0.45% 64
2022
Q3
$6.19M Sell
76,603
-315
-0.4% -$28.3K 0.62% 43
2022
Q2
$6.9M Buy
76,918
+242
+0.3% +$24.5K 0.65% 44
2022
Q1
$8.51M Sell
76,676
-1,827
-2% -$193K 0.7% 41
2021
Q4
$8.12M Sell
78,503
-1,271
-2% -$147K 0.61% 50
2021
Q3
$10M Buy
79,774
+354
+0.4% +$45.8K 0.83% 35
2021
Q2
$9.86M Sell
79,420
-826
-1% -$104K 0.84% 33
2021
Q1
$9.48M Sell
80,246
-1,082
-1% -$127K 0.88% 32
2020
Q4
$9.53M Sell
81,328
-307
-0.4% -$33.8K 0.94% 31
2020
Q3
$8.48M Buy
81,635
+593
+0.7% +$59.6K 0.94% 30
2020
Q2
$7.43M Sell
81,042
-405
-0.5% -$38.8K 0.89% 30
2020
Q1
$7.34M Buy
81,447
+672
+0.8% +$71.5K 1.02% 29
2019
Q4
$9.16M Buy
80,775
+1,264
+2% +$139K 1.01% 29
2019
Q3
$8.64M Buy
79,511
+291
+0.4% +$30.4K 1.04% 26
2019
Q2
$7.71M Buy
79,220
+1,090
+1% +$99.5K 0.95% 30
2019
Q1
$7.12M Buy
78,130
+173
+0.2% +$15.5K 0.94% 30
2018
Q4
$7.09M Buy
77,957
+1,762
+2% +$165K 1.06% 23
2018
Q3
$7.5M Buy
76,195
+1,084
+1% +$100K 1% 29
2018
Q2
$6.43M Buy
75,111
+1,462
+2% +$122K 0.92% 30
2018
Q1
$5.91M Buy
73,649
+555
+0.8% +$45.8K 0.9% 32
2017
Q4
$5.9M Sell
73,094
-1,911
-3% -$153K 0.92% 30
2017
Q3
$5.83M Sell
75,005
-5,140
-6% -$427K 0.98% 28
2017
Q2
$7.11M Buy
80,145
+5,497
+7% +$464K 1.2% 17
2017
Q1
$6.01M Sell
74,648
-14,337
-16% -$1.12M 1.11% 23
2016
Q4
$6.34M Sell
88,985
-4,297
-5% -$338K 1.28% 23
2016
Q3
$8.06M Buy
93,282
+2,906
+3% +$253K 1.52% 15
2016
Q2
$7.84M Buy
90,376
+561
+0.6% +$45.4K 1.6% 17
2016
Q1
$6.74M Buy
89,815
+6,402
+8% +$482K 1.33% 25
2015
Q4
$6.42M Buy
83,413
+16,607
+25% +$1.25M 1.27% 27
2015
Q3
$4.47M Buy
66,806
+11,130
+20% +$820K 1.02% 34
2015
Q2
$4.13M Buy
55,676
+8,532
+18% +$652K 0.92% 38
2015
Q1
$3.68M Buy
47,144
+39,926
+553% +$3.03M 0.83% 43
2014
Q4
$521K Buy
7,218
+3,211
+80% +$223K 0.12% 117
2014
Q3
$248K Buy
4,007
+600
+18% +$38.1K 0.06% 162
2014
Q2
$217K Buy
+3,407
New +$207K 0.05% 168

Other funds holding MDT

Appleton Partners's MDT Position: Q2 2026 in Review

Appleton Partners reduced its Medtronic (MDT) stake by 2.8% in Q2 2026, selling an estimated $71.3K and leaving 31,102 shares worth $2.43M. The position accounts for 0.15% of the portfolio, ranked #103.

Appleton Partners first reported a position in MDT in Q2 2014 and has held it in 49 quarters since. The position peaked at $10M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Appleton Partners held 31,102 shares of Medtronic worth $2.43M as of Q2 2026.
  • Appleton Partners sold 884 Medtronic shares in Q2 2026, an estimated $71.3K.
  • Medtronic made up 0.15% of Appleton Partners's portfolio in Q2 2026, its #103 holding.
  • Appleton Partners first reported a position in Medtronic in Q2 2014 and has held it in 49 quarters since.
  • Appleton Partners's Medtronic position peaked at $10M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.